Published 2020 | Version v1
Publication

Cladribine vs other drugs in MS: Merging randomized trial with real-life data

Description

Cladribine tablets were tested against placebo in randomized controlled trials (RCTs). In this study, the effectiveness of cladribine vs other approved drugs in patients with relapsing-remitting MS (RRMS) was compared by matching RCT to observational data.

Additional details

Created:
April 14, 2023
Modified:
November 29, 2023